Fifteen years after a chance meeting started their partnership, a compound Jeffrey Arterburn, and Eric Prossnitz discovered may lead to new skin cancer treatments.
Eric Prossnitz, (left) University of New Mexico professor in the Department of Internal Medicine, and chief of the Division of Molecular Medicine, and Jeffrey Arterburn, Regents’ professor in the Department of Chemistry and Biochemistry at the New Mexico State University, discovered a compound that may lead to new skin cancer treatments. (UNM courtesy photo)
Arterburn, a Regents professor in chemistry and biochemistry at New Mexico State University, and Prossnitz, a professor in the Department of Internal Medicine at The University of New Mexico Comprehensive Cancer Center, met after a regional scientific conference in 2003. Arterburn told Prossnitz about some compounds he had developed that might help Prossnitz’s research. The two quickly realized that their work dovetailed nicely.
Read Full Article: